Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ivana Milosevic

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
Journal of Infection in Developing Countries|February 24, 2020
Risk factors associated with poor clinical outcome in pyogenic spinal infections: 5-years' intensive care experienceBranko Milosevic, Muge Cevik, Aleksandar Urosevic, et al.
Germs|December 3, 2025
Doravirine/lamivudine/tenofovir disoproxil fumarate (DOR/3TC/ TDF) treatment in people living with HIV: A single-center real-world experience from Belgrade, SerbiaMarko Markovic, Jovan Ranin, Aleksa Despotovic, et al.
Journal of Infection in Developing Countries|October 31, 2015
Oral teicoplanin for successful treatment of severe refractory Clostridium difficile infectionNatasa Popovic, Milos Korac, Zorica Nesic, et al.
Journal of Infection in Developing Countries|October 22, 2024
Correlation of the severity of the clinical presentation of SARS-CoV-2 pneumonia with respiratory function parameters in the post-COVID periodSlobodan Belic, Andjelka Ivanovic, Aleksandra Todorovic, et al.
International Journal of Molecular Sciences|November 25, 2023
HCV and HCC Tango-Deciphering the Intricate Dance of Disease: A Review ArticleIvana Milosevic, Nevena Todorovic, Ana Filipovic, et al.
Journal of Infection in Developing Countries|March 10, 2025
Tocilizumab treatment of COVID-19: relevance of delay in therapy initiation in middle-income countriesBranko Beronja, Olja Stevanović, Nataša Nikolić, et al.
Journal of Infection in Developing Countries|March 9, 2020
Micro-elimination of HCV as a possible therapeutic strategy: our experience and a review of literatureKsenija Bojovic, Jasmina Simonovic-Babic, Zeljko Mijailovic, et al.
Journal of Infection in Developing Countries|December 13, 2019
The prevalence and the risk factors for hepatitis C virus infection in SerbiaNikola Mitrovic, Dragan Delic, Ljiljana Markovic Denic, et al.
Plos One|March 10, 2021
Helicobacter pylori infection rates in dyspeptic Serbian HIV-infected patients compared to HIV-negative controlsAleksandra Radovanovic Spurnic, Zoran Bukumiric, Djordje Jevtovic, et al.
Journal of Infection in Developing Countries|June 12, 2024
Molnupiravir's real-world effectiveness in COVID-19 outpatients at high risk of severe disease: a single-center studyIvana I Gmizic, Aleksandra Barac, Nevena Todorovic, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Journal of Infection in Developing Countries|February 24, 2020
Risk factors associated with poor clinical outcome in pyogenic spinal infections: 5-years' intensive care experienceBranko Milosevic, Muge Cevik, Aleksandar Urosevic, et al.
Germs|December 3, 2025
Doravirine/lamivudine/tenofovir disoproxil fumarate (DOR/3TC/ TDF) treatment in people living with HIV: A single-center real-world experience from Belgrade, SerbiaMarko Markovic, Jovan Ranin, Aleksa Despotovic, et al.
Journal of Infection in Developing Countries|October 31, 2015
Oral teicoplanin for successful treatment of severe refractory Clostridium difficile infectionNatasa Popovic, Milos Korac, Zorica Nesic, et al.
Journal of Infection in Developing Countries|October 22, 2024
Correlation of the severity of the clinical presentation of SARS-CoV-2 pneumonia with respiratory function parameters in the post-COVID periodSlobodan Belic, Andjelka Ivanovic, Aleksandra Todorovic, et al.
International Journal of Molecular Sciences|November 25, 2023
HCV and HCC Tango-Deciphering the Intricate Dance of Disease: A Review ArticleIvana Milosevic, Nevena Todorovic, Ana Filipovic, et al.
Journal of Infection in Developing Countries|March 10, 2025
Tocilizumab treatment of COVID-19: relevance of delay in therapy initiation in middle-income countriesBranko Beronja, Olja Stevanović, Nataša Nikolić, et al.
Journal of Infection in Developing Countries|March 9, 2020
Micro-elimination of HCV as a possible therapeutic strategy: our experience and a review of literatureKsenija Bojovic, Jasmina Simonovic-Babic, Zeljko Mijailovic, et al.
Journal of Infection in Developing Countries|December 13, 2019
The prevalence and the risk factors for hepatitis C virus infection in SerbiaNikola Mitrovic, Dragan Delic, Ljiljana Markovic Denic, et al.
Plos One|March 10, 2021
Helicobacter pylori infection rates in dyspeptic Serbian HIV-infected patients compared to HIV-negative controlsAleksandra Radovanovic Spurnic, Zoran Bukumiric, Djordje Jevtovic, et al.
Journal of Infection in Developing Countries|June 12, 2024
Molnupiravir's real-world effectiveness in COVID-19 outpatients at high risk of severe disease: a single-center studyIvana I Gmizic, Aleksandra Barac, Nevena Todorovic, et al.
Pageof 5